Keyword: Sanofi

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...

Plant Construction & Process Technology

The Chemical Footprint in Pharma

26.04.2017 - The chemical industry is the most important supplier of the pharmaceutical industry, but it can´t keep pace with the economic strength and R&D intensity of pharma. This underlines...

News

Pharma Chiefs Call for Decision on EMA

25.04.2017 - Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a...

News

FDA Drug Approvals up Sharply in Q1

24.04.2017 - After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...

News

MedImmune and Sanofi Pasteur in LRTI Drug Pact

29.03.2017 - AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...

News

Sanofi and Lonza to Build Biologics Plant

28.02.2017 - French drugmaker Sanofi and Swiss fine chemicals producer and toll manufacturing specialist Lonza plan to jointly invest in a new €270 million large-scale mammalian cell culture...

News

Sanofi to Sell Five OTC Products to Ipsen

15.02.2017 - French pharmaceutical producer Sanofi has agreed to sell five consumer healthcare products in certain European territories to compatriot drugmaker Ipsen for €83 million. The cash...

News

J&J Clinches Actelion for $30 Billion

27.01.2017 - Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...